BPA for ojemda
Active Awarded Last action
- Contract number
- 36E79725A0007
- Awardee
-
Day One Biopharmaceuticals, Inc. UEI G9SZJB5MEHR3
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 83% complete
- IDV ceiling
- $15,000,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
Day One Biopharmaceuticals, Inc. has been awarded a single-award Blanket Purchase Agreement (BPA) by the National Acquisition Center for the supply of OJEMDA and related pharmaceutical products to federal healthcare agencies. The BPA, valued at $15.0 million with a completion date of March 7, 2027, was awarded on March 8, 2025, and represents Exercise Option Year 1 of the underlying indefinite delivery vehicle (BPA 36E79725A0007). The contract was issued without set-aside provisions, indicating open competition. The prime contractor is positioned under the Federal Supply Schedule Pharmaceuticals and Drugs (FSS-61-IB) category, which establishes the pricing and terms framework for this vehicle. This BPA enables federal agencies, particularly within the Department of Veterans Affairs system, to procure pharmaceutical products through a streamlined ordering mechanism that eliminates the need for individual competitive solicitations on a per-order basis.
Day One Biopharmaceuticals, Inc. specializes in supplying specialized biopharmaceutical products, with demonstrated federal contract experience delivering OJEMDA and TOVORAFENIB 100 milligram tablets to Veterans Integrated Service Networks. The company's capabilities encompass drugs, pharmaceuticals, and hematology-related medical products across multiple contract vehicles and ceiling values ranging from $25,000 to $15.0 million. The BPA structure allows federal healthcare systems to efficiently procure pharmaceutical inventory from an established contractor with pre-negotiated pricing, reducing procurement cycle times and administrative burden while ensuring consistent supply chain access to specialized medications required by the Veterans Affairs healthcare system and other eligible federal agencies.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79725A0007?
36E79725A0007 was awarded to Day One Biopharmaceuticals, Inc. by National Acquisition Center (Headquarters) on March 8, 2025.
How much is contract 36E79725A0007 worth?
36E79725A0007's own ceiling is $15,000,000.
Who can order from contract 36E79725A0007?
36E79725A0007 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79725A0007 under another contract?
Yes. 36E79725A0007 is a blanket purchase agreement under 36F79725D0029, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79725A0007 competed?
The extent of competition for 36E79725A0007 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV